Navigation Links
Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season
Date:5/6/2008

"Clear to Drive" Campaign Urges Allergy Sufferers to Check Medicine Labels

for Drowsiness Warnings Before Getting Behind the Wheel

KENILWORTH, N.J., May 6 /PRNewswire-FirstCall/ -- Summer is fast approaching, bringing sunshine, vacation days, and trips to the beach. But the warmer weather also marks a peak in seasonal allergies and the beginning of a busy driving season. According to a recent survey, seven out of ten Americans believe they will spend some time driving this Memorial Day weekend.

This year, the makers of the non-drowsy allergy medication CLARITIN(R) are partnering with Lori Loughlin, a popular actress, mom and allergy sufferer, best known for her role as Rebecca Donaldson on the hit sitcom Full House. The campaign aims to raise awareness about the importance of reading medicine labels, including allergy medicines, for warnings about drowsiness before they get behind the wheel.

Like many working moms, Lori spends hours each day shuttling her children to school, activities, and play-dates in the high-traffic Los Angeles area. It's especially important to Lori that she's focused behind the wheel with her most precious cargo in the back seat.

"As an allergy sufferer, I was surprised to learn that some over-the- counter medicines may cause drowsiness. In fact, the allergy medicine I used to take made me drowsy. I thought there was something wrong with me because I was so sleepy -- which was pretty dangerous considering all the driving I do with my kids," said Lori. "Then I discovered CLARITIN, which relieves my worst allergy symptoms for 24 hours without making me drowsy. When you spend as much time driving as I do, you need to be focused."

Lori is not alone -- in fact many drivers don't realize that some common over-the-counter medicines could cause drowsiness. According to a recent survey, four in 10 Americans (38%) report that there have been times when they were driving and realized that the medicine they had taken was making them drowsy.

"We're thrilled that Lori, a well-known actress and mom, recognizes the importance of reading medicine labels for warnings about drowsiness before she gets behind the wheel," said TJ Higgins, Group Vice President, Marketing, Schering-Plough Consumer Healthcare. "Lori is participating in the "Clear to Drive" campaign to help share her story with millions of Americans who might not know that their medicines may cause drowsiness."

For tips on safe driving and to learn more about treating allergies, visit http://www.cleartodrive.com.

About Lori Loughlin

Lori Loughlin is a popular TV and movie actress best known for her role as Rebecca Donaldson on the hit sitcom Full House. Her latest film, "Old Dogs," which also stars John Travolta, Robin Williams, and Seth Rogen, is scheduled to be released next year. Lori resides in Los Angeles with her husband, Mossimo Giannulli, creator of the popular "Mossimo" clothing line, and their three children.

About CLARITIN

All CLARITIN brand products are available without a prescription, including: CLARITIN(R) Tablets, a once-daily full prescription strength, non- drowsy formulation; CLARITIN(R) RediTabs(R) Tablets, a novel once-daily formulation in a quickly dissolving tablet for ages 6 and older; CLARITIN-D(R) 24-hour and 12-hour Extended Release Tablets, with the decongestant pseudoephedrine now located behind the counter; CHILDREN'S CLARITIN(R) Syrup, a liquid formulation for children ages 2 and older in grape and fruit flavors; CHILDREN'S CLARITIN(R) Grape Chewables, a chewable tablet for children ages 2 and older; and CLARITIN Hives Relief(TM) tablets.

CLARITIN is the No. 1 physician-recommended and pediatrician-recommended over-the-counter antihistamine brand for allergic rhinitis. The CLARITIN(R) Rx-to-OTC switch in 2002 was the largest switch ever-and the first and only for a non-sedating antihistamine. For more information on allergies and treatment, visit http://www.CLARITIN.com.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference
2. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
3. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
4. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
5. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
6. Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
7. Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance
8. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
9. Stemline Therapeutics Raises $12.5 Million
10. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
11. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... 28, 2017 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB:REPCF) ... regenerative medicine company developing unique biologic products for pattern ... chronic tendon degeneration, today announced it has recently signed ... committed to work with RepliCel to get the Company,s ... ...
(Date:2/28/2017)... -- The Biotech industry is today,s focus on ... ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ), Aurinia Pharmaceuticals ... ARNA ), and Marinus Pharmaceuticals Inc. (NASDAQ: ... which was narrowly mixed on Monday, February 27 th , ... 0.1%, while shares of health care companies in the S&P ...
(Date:2/27/2017)... - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), reported ... 2017 a total of 10,672,750 common share purchase warrants have ... Proceeds from the exercise of these warrants totalled $1,387,458 and ... ... for this expression of confidence by our warrant holders. This ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
Breaking Biology Technology:
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):